3-Hydroxyglutaric acid fails to affect the viability of primary neuronal rat cells

Neurobiology of Disease

Volumn 16, Issue 3, 2004, Pages 581-584

  Freudenberg, F ^a,b   Lukacs, Z ^a   Ullrich, K ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

amino butyric acid; 3 hydroxyglutaric acid; 3OHG; dizocilpine maleate; GA I; GABA; Glutaric aciduria type I; Metabolic diseases; MK801; N methyl D aspartate; Neurodegeneration; NMDA; NMDA receptors; Organic acids

Indexed keywords

3 HYDROXYGLUTARIC ACID; DIZOCILPINE; GLUTARIC ACID DERIVATIVE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ACIDURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN NERVE CELL; CELL CULTURE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; INCUBATION TIME; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

ACIDS; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; GLUTARATES; GLUTARYL-COA DEHYDROGENASE; NERVE DEGENERATION; NEURONS; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 3242706145     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2004.05.001     Document Type: Article

References (28)

1. Amir N., El-Peleg O., Shalev R.S., Christensen E. Glutaric aciduria type I: clinical heterogeneity and neuroradiologic features. Neurology. 37:1987;1654-1657
2. Banker G., Goslin K. Culturing Nerve Cells. 1991;MIT Press, London, England
3. Bjugstad K.B., Goodman S.I., Freed C.R. Age of symptom onset predicts severity of motor impairment and clinical outcome of glutaric acidemia type 1. J. Pediatr. 137:2000;681-686
4. Bjugstad K.B., Zawada W.M., Goodman S.I., Freed C.R. IGF-1 and bFGF reduce glutaric acid and 3-hydroxyglutaric acid toxicity in striatal cultures. J. Inherited Metab. Dis. 24:2001;631-647
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254
6. Carmichael J., DeGraff W.G., Gazdar A.F., Minna J.D., Mitchell J.B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensivity testing. Cancer Res. 47:1987;842-936
7. Das A.M., Lücke T., Ullrich K. Glutaric aciduria I: creatine supplementation restores creatinephosphate levels in mixed cortex cells from rat incubated with 3-hydroxicglutarate. Mol. Genet. Metab. 78(2):2003 (Feb.);108-111. [United States]
8. DeMello C.F., Kölker S., Ahlemeyer B., et al. Intrastriatal administration of 3-hydroxyglutaric acid induces convulsions and striatal lesions in rats. Brain Res. 916:2001;70-75
9. Flott-Rahmel B., Falter C., Schluff P., et al. Nerve cell lesions cause by 3-hydroxyglutaric acid: a possible mechanism for neurodegeneration in glutaric academia I. J. Inherited Metab. Dis. 20:1997;387-390
10. Forstner R., Hoffmann G.F., Gassner I., Heidemann P., De Klerk J.B.C., Lawrenz-Wolf B., Doringer E., Weiß-Wichert P., Tröger J., Colombo J.P., Plöchl E. Glutaric aciduria type I: ultrasonographic demonstration of early signs. Pediatr. Radiol. 29:1999;138-143
11. Freudenberg F., Lukacs Z., Ullrich K., Braulke T. Primary cell cultures as an in vitro model for glutaric aciduria I. J. Inherited Metab. Dis. 25:2002;150
12. Goodman S.I., Biery B.J. Glutaric acidemia (type 1). Ment. Retard. Dev. Disabil. Res. Rev. 2:1996;155-159
13. Goodman S.I., Kohlhoff J.G. Glutaric aciduria: inherited deficiency of glutaryl-CoA dehydrogenase activity. Biochem. Med. 13:1975;138-140
14. Hoffmann G.F., Trefz F.K., Barth P., Böhles J.H., Biggemann B., Bremer H.J., Christensen E., Frosch M., Hanefeld F., Hunnemann D.H., Jacobi H., Kurlemann G., Lawrenz-Wolf B., Rating D., Roe C.R., Schutgens R.B.H., Ullrich K., Weisser J., Wendel U., Lehnert W. Glutaryl-CoA deficiency: a distinct encephalopathy. Pediatrics. 88:1991;1194-1203
15. Hoffmann G.F., Athanassopoulos S., Burlina A.B., Duran M., de Klerck J.B.C., Lehnert W., Leonard J.V., Monavari A.A., Müller E., Muntau A.C., Naughten E.R., Plecko-Starting B., Superti-Furga A., Zschocke J., Christensen E. Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency. Neuropediatrics. 27:1996;115-123
16. Ikonomidou C., Turski L. Excitotoxicity and neurodegenerative diseases. Curr. Opin. Neurol. 8:1995;487-497
17. Khan S., Kayahara M., Joashi U., Mazarakis N.D., Sarraf C., Edwards A.D., Hughes M.N., Mehmet H. Differential induction of apoptosis in Swiss 3T3 cells by nitric oxide and the nitrosonium cation. J. Cell Sci. 110:1997;2315-2322
18. Koeller D.M., Woontner M., Crnic L.S., Kleinschmidt-DeMasters B., et al. Biochemical, pathologic and behavioural analysis of a mouse model of glutaric acidemia type I. Hum. Mol. Genet. 11:2002;347-357
19. Kölker S., Ahlemeyer B., Krieglstein J., Hoffmann G.F. 3-Hydroxyglutaric and glutaric acids are neurotoxic through NMDA receptors in vitro. J. Inherited Metab. Dis. 22:1999;259-262
20. Kölker S., Ahlemeyer B., Krieglstein J., Hoffmann G.F. Cerebral organic disorders induce neuronal damage via excitotoxic organic acids in vitro. Amino Acids. 18:2000;31-40
21. Kölker S., Ahlemeyer B., Krieglstein J., Hoffmann G.F. Maturation-dependent neurotoxicity of 3-hydroxyglutaric and glutaric acids in vitro: a new pathophysiologic approach to glutaryl-CoA dehydrogenase. Pediatr. Res. 47:2000;495-503
22. Kölker S., Ahlemeyer B., Krieglstein J., Hoffmann G.F. Contribution of reactive oxygen species to 3-hydroxyglutarate neurotoxicity in primary neuronal cultures from chick embryo telencephalons. Pediatr. Res. 50:2001;76-82
23. Laird P., Zijderveld A., Linders K., Rudnicki M., Jaenisch M., Berns A. Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 19:1991;4293
24. Lipton S.A., Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. NEJM. 330:1994;613-622
25. Monyer H., Burnashev N., Laurie D.J., Sakmann B., Seeburg P.H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron. 12:1994;529-540
26. Morley P., Small D.L., Murray C.L., Mealing G.A., Poulter M.O., Durkin J.P., Stanimirovic D.B. Evidence that functional glutamate receptors are not expressed on rat or human cerebromicrovascular endothelial cells. J. Cereb. Flow Metab. 18:1998;396-406
27. Ullrich K., Flott-Rahmel B., Schluff P., et al. Glutaric aciduria type 1 pathomechanisms of neurodegeneration. J. Inherited Metab. Dis. 22:1999;392-403
28. Wenzel A., Fritschy J.M., Mohler H., Benke D. NMDA receptor heterogeneity during postnatal development of the rat brain: differential expression of the NR2A, NR2B and NR2Csubunit proteins. J. Neurochem. 68:1997;469-478